WIRB-Copernicus Group (WCG), the world s largest provider of regulatory and ethical review services and software to support clinical research, announced today that it has been chosen by Cancer Treatment Centers of America (CTCA) to help expand its clinical research program. WCG will assOriginal Article
You may also like
Exploring 3D Printing for Solid Dosage Drugs
Control Strategies and Method Development for...
CPHI Milan 2024: Fill/Finish and Sustainability
CPHI Milan 2024: Industry Trends Impacting Oral Solid...
CPHI Milan 2024: Evolution of Coating Design
Colorcon and LOTTE Fine Chemical Announce Partnership
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.